Whole-brain N-acetylaspartate MR spectroscopic quantification: Performance comparison of metabolite versus lipid nulling

American Journal of Neuroradiology

Volumn 29, Issue 8, 2008, Pages 1441-1445

  Hovener J B ^a,b   Rigotti, D J ^a   Amann, M ^c   Liu, S ^a   Babb, J S ^a   Bachert, P ^b   Gass, A ^c   Grossman, R I ^a   Gonen, Oded ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUESTIONNAIRE; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS;

ADULT; ASPARTIC ACID; BRAIN; FEMALE; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 51649111209     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1171     Document Type: Article

References (29)

1. Tallan HH, Moore S, Stein WH. N-acetyl-L-aspartic acid in brain. J Biol Chem 1956;219:257-64
2. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson Series B 1993;102:9-19
3. Jansen JF, Backes WH, Nicolay K, et al. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006;240:318-32
4. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 2003;28:941-53
5. Moffett JR, Ross B, Arun P, et al. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89-131
6. Sager TN, Laursen H, Fink-Jensen A, et al. N-acetylaspartate distribution in rat brain striatum during acute brain ischemia. J Cereb Blood Flow Metab 1999;19:164-72
7. Arnold DL, de Stefano N, Matthews PM, et al. N-acetylaspartate: usefulness as an indicator of viable neuronal tissue. Ann Neurol 2001;50:823-25
8. Ross BD, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001;265:54-84
9. Rigotti DJ, Inglese M, Gonen O. Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. AJNR Am J Neuroradiol 2007;28:1843-49
10. Li BS, Babb JS, Soher BJ, et al. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002;47:439-46
11. Mathiesen HK, Tscherning T, Sorensen PS, et al. Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis. Magn Reson Med 2005;53:750-59
12. Hetherington HP, Pan JW, Mason GF, et al. 2D 1H spectroscopic imaging of the human brain at 4.1 T. Magn Reson Med 1994;32:530-34
13. Spielman DM, Pauly JM, Macovski A, et al. Lipid-suppressed single- and multisection proton spectroscopic imaging of the human brain. J Magn Reson Imaging 1992;2:253-62
14. Gonen O, Viswanathan AK, Catalaa I, et al. Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy. Magn Reson Med 1998;40:684-89
15. Moonen CTW, Sobering G, van Zijl PCM, et al. Proton spectroscopic imaging of human brain. J Magn Reson 1992;98:556-75
16. Inglese M, Ge Y, Filippi M, et al. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage 2004;21:1825-29
17. Rigotti DJ, Inglese M, Babb JS, et al. Serial whole-brain N-acetylaspartate concentration in healthy young adults. AJNR Am J Neuroradiol 2007;28:1650-51
18. Benedetti B, Rigotti DJ, Liu S, et al. Reproducibility of the whole-brain N-acetylaspartate level across institutions, MR scanners, and field strengths. AJNR Am J Neuroradiol 2007;28:72-75
19. Hu J, Javaid T, Arias-Mendoza F, et al. A fast, reliable, automatic shimming procedure using 1H chemical-shift-imaging spectroscopy. J Magn Reson B 1995;108:213-19
20. Li S, Dardzinski BJ, Collins CM, et al. Three-dimensional mapping of the static magnetic field inside the human head. Magn Reson Med 1996;36:705-14
21. Gonen O, Grossman RI. The accuracy of whole brain N-acetylaspartate quantification. Magn Reson Imaging 2000;18:1255-58
22. Behar KL, Rothman DL, Spencer DD, et al. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302
23. Traber F, Block W, Lamerichs R, et al. 1H metabolite relaxation times at 3.0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004;19:537-45
24. Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001;153:155-77
25. Ogg RJ, Kingsley PB, Taylor JS. WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994;104:1-10
26. Hore PJ. Solvent Suppression. In: NJ Oppenheimer and TL James, eds. Methods in Enzymology: Nuclear Magnetic Resonance, Part A: Special Techniques and Dynamics. Vol. 176. San Diego: Academic Press; 1989:64-77.
27. Ebel A, Govindaraju V, Maudsley AA. Comparison of inversion recovery preparation schemes for lipid suppression in 1H MRSI of human brain. Magn Reson Med 2003;49:903-08
28. Hoult DI, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 1976;24:71-85
29. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117(pt 1):49-58